Lagis Enterprise Co., Ltd. (TPEX:6730)

Market Cap	1.34B +11.3%
Revenue (ttm)	470.29M +0.1%
Net Income	68.72M -2.7%
EPS	2.09 -4.5%
Shares Out	36.30M
PE Ratio	17.73
Forward PE	n/a
Dividend	1.00 (2.70%)
Ex-Dividend Date	Jul 17, 2025

Volume	23,000
Average Volume	43,748
Open	37.00
Previous Close	37.45
Day's Range	36.70 - 37.00
52-Week Range	33.10 - 52.20
Beta	0.20
RSI	47.74
Earnings Date	Apr 24, 2026

About Lagis Enterprise

Lagis Enterprise Co., Ltd. engages in the manufacturing, processing, and sale of surgical instruments, equipment, and related medical devices Taiwan and China. Its products include trocars, include optical tip trocar, dilating tip trocar, shielded bladed tip trocar, blunt tip trocar, TRE trocar system, balloon trocar; single port surgery devices, include advanced single port device, single port kit for TAMIS, and advanced single port device for vNOTES; path cap and shield wound reactors; energy bipolar forceps; suction irrigation systems and ir...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2004
• Employees: 202
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6730

Financial Performance

In 2024, Lagis Enterprise's revenue was 454.36 million, a decrease of -1.21% compared to the previous year's 459.93 million. Earnings were 68.24 million, an increase of 6.44%.